1,5-anhydroglucitol has been researched along with Acute Lymphoid Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, N; Ju, X; Li, D; Liu, L; Ma, H; Shi, Q; Wu, M; Zhu, H | 1 |
| Chi, C; Ju, X; Li, D; Liu, L; Ma, H; Shi, Q; Wu, M; Zhang, S; Zhu, H | 1 |
2 other study(ies) available for 1,5-anhydroglucitol and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
1,5-Anhydroglucitol promotes pre-B acute lymphocytic leukemia progression by driving glycolysis and reactive oxygen species formation.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Child; Extracellular Signal-Regulated MAP Kinases; Glycolysis; Humans; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species | 2023 |
1,5-AG suppresses pro-inflammatory polarization of macrophages and promotes the survival of B-ALL in vitro by upregulating CXCL14.
Topics: Chemokines, CXC; Child; Humans; Immunotherapy; Macrophages; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Microenvironment | 2023 |